Mike Hsu aims to stoke the consumer company’s growth by veering into Kenvue’s higher-margin but risky health products.

One of biggest takeovers so far this year will create a global company with annual revenues of roughly $32 billion.

Kimberly-Clark plans a $48.7B Kenvue acquisition to drive growth and synergies. Learn the deal's risks, impacts, and KMB's ...

The owner of Kleenex and Huggies will acquire the company that has fought unproven claims by the Trump administration that a ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a huge consumer ...

Kleenex and Cottonelle maker Kimberly-Clark said it's buying Tylenol maker Kenvue in a $48.7 billion deal. Kenvue ( KVUE) ...

Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive ...

The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven ...

One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common ...

Kimberly-Clark Corp. will acquire Tylenol maker Kenvue Inc. in a cash and stock deal valued at almost $49 billion the two companies announced Nov. 3.

Summit, NJ-based Kenvue shareholders will own about 46% in what is one of the largest corporate takeovers this year.

Kimberly-Clark is making a big move with a nearly $50 billion acquisition. The North Texas company plans to acquire Kenvue ...